Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measures-Reference-Cited by-同舟云学术

Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measures

Published:2018-10 Issue: Volume:268 Page:80-84
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Di Fusco Stefania Angela,Lucà Fabiana,Benvenuto Manuela,Iorio Annamaria,Fiscella Damiana,D'Ascenzo Fabrizio,Madeo Andrea,Colivicchi Furio,Di Lenarda Andrea,Gulizia Michele Massimo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060;Krijthe;Eur. Heart J.,2013

2. RE-LY steering committee and investigators. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2009

3. At al.; ROCKET AF investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N. Engl. J. Med.,2011

4. ARISTOTLE committees and investigators. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N. Engl. J. Med.,2011

5. ENGAGE AF-TIMI 48 investigators. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N. Engl. J. Med.,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative Management of Valvular Heart Disease in Patients Undergoing Non-Cardiac Surgery;Journal of Clinical Medicine;2024-05-30

2. Exploring the Perioperative Use of DOACs, off the Beaten Track;Journal of Clinical Medicine;2024-05-24

3. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios;Journal of Clinical Medicine;2023-09-13

4. Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation;Frontiers in Cardiovascular Medicine;2023-05-25

5. Coagulation factors XI and XII as possible targets for anticoagulant therapy;Thrombosis Research;2022-06